fbpx

Bhubaneswar-based startup EzeRx presents the world’s first non-invasive treatments

EzeRx is a Bhubaneswar-based startup that makes non-invasive devices that allow you to get your blood tests done at an affordable price and in record time — and all without having to draw a single drop of blood.

The portable device EzeCheck checks for five different blood parameters — namely hemoglobin, oxygen saturation, bilirubin, creatinine, and blood glucose levels — just by a patient placing his ring finger on the device. The data for the patient is delivered in 10 to 20 seconds, and each blood test costs Rs 35.

Founded in 2018 by Partha Pratim Das, along with Chaitali Roy and Sudip Roy Chowdhury, EzeRX, which stands for ‘Easy for prescription,’ offers easy and painless diagnostic solutions for identifying primary health parameters at an early stage. The startup, which was previously based in Kolkata, is working towards making the adoption of preventive healthcare more appealing and accessible for Indians through easy, affordable, diagnostic solutions.

“About one out of every 11 adults post the age of 45 are diagnosed with chronic kidney diseases. Almost 80 percent of people over 45 years of age are suffering from diabetes and 2 out of 3 women have low hemoglobin. Besides, almost one million people are being diagnosed with liver problems every year. So these are very big problems in the country and if it can be predicted right at the bottom of the pyramid, it will be a big game-changer in the healthcare sector,” says Partha.

Partha explained that the EzeCheck device has received the Central Drugs Standard Control Organisation (CDSCO) certification and has an accuracy rate of over 95 percent. EzeRx is now planning to get certifications to expand into international markets. Making blood tests a painless experience Partha revealed that the blood results can be generated on the EzeRx device that works on spectroscopy, and can be accessed using the mobile app. The report can also be shared within seconds through WhatsApp.

Before this, the startup had also built a non-invasive, non-contact, IoT-enabled portable diagnostic device called AJO (short for anemia, jaundice, and oxygen saturation) for testing anemia, liver, and lung-related health issues. AJO too was designed to make the testing process bloodless and painless as it measured the spectroscopic signal emitting from the conjunctiva, the clear membrane that lines the inside of the eyelids and covers the white of the eye to provide data on one’s hemoglobin, bilirubin, and oxygen saturation.

While AJO collects data by scanning the eyes of the users, EzeCheck is another version of the blood parameters testing device that collects data with just a tap of the finger. EzeCheck is a battery-operated device with a capacity of 2500 mAh and can operate for 10 to 12 hours. The device is manufactured in India, and all components, except one which is imported from Japan, are from India.

Partha says, “Nearly 75 percent of our population is from rural India and they believe in curative healthcare approach instead of preventative. And that’s a big problem. So, the idea is to identify the primary health parameters in the early stage, so we can easily predict liver, lungs, and kidney problems, or even nutrition problems like anemia and detect random blood glucose, so that patients can then go in for a complete cure. That’s the idea.”

Partha explains that EzeRx has two main business verticals — first, where it offers non-invasive prescreening and diagnostics devices, and second, where it is building teledentistry networks in rural and semi-urban areas. Apart from this, EzeRx also provides an OralOScope solution for detecting oral cancers and pre-cancerous lesions. It also has a teledentistry platform,
Aarogya, to aid rural and semi-urban areas to get access to quality dental treatments.

Partha says that the EzeCheck device will be available for B2B clients including hospitals, nursing homes, NGOs, CSR organizations under a device-as-a-service (DaaS) model. “We will not be selling the devices but are operating on the DaaS model. Initially, we are charging around Rs 35,000 and 1500 tests including creatine, blood glucose can be done using the device,” he adds.

Tags

top